Filing Flows › Ideaya Biosciences (IDYA) › Q3 2026 › vs Q2 2026
Ideaya Biosciences (IDYA) Q3 2026 vs Q2 2026 (quarter over quarter)
Ideaya Biosciences's revenue rose $1.4M (+16%) from $8.9M in Q2 2026 to $10.2M in Q3 2026.
Ideaya Biosciences, Q3 2026: revenue $10.2M (-95% year over year), net loss $126M, operating cash flow −$93.5M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $10.2M | $8.9M | $1.4M | +16% |
| Other income, net | $11.9M | $9.8M | $2.0M | +21% |
| Net loss | $126M | $112M | $13.3M | +12% |
| Costs & expenses | $148M | $131M | $16.7M | +13% |
| Operating costs | $148M | $131M | $16.7M | +13% |
| Research & development | $122M | $83.0M | $38.6M | +46% |
| General & admin | $26.3M | $22.5M | $3.8M | +17% |
| Operating cash sources | $126M | $112M | $13.3M | +12% |
| Depreciation & amortization | $614K | $688K | −$74K | -11% |
| Share-based compensation | $17.7M | $16.7M | $1.1M | +6% |
| Working capital & other | $13.9M | $6.9M | $7.0M | +102% |
| Cash used in operations | $93.5M | $88.2M | $5.3M | +6% |
| Net loss absorbed | $126M | $112M | $13.3M | +12% |
Questions
How much did Ideaya Biosciences's revenue grow quarter over quarter in Q3 2026?
Ideaya Biosciences's revenue rose $1.4M (+16%) from $8.9M in Q2 2026 to $10.2M in Q3 2026.